Biotech Stocks Make Q4 Comeback in 2019: Our Calls Were Excellent….Update-4 Biotechs are lagging
Update-4 January 2 , 2020. 12:11 EST..... Biotechs and Healthcare lagging a bit in the New Year. Watch rotation into other sectors -tech, financial, energy; update at end of week. Many mid and small caps are weak despite NAZ up 0.66%. Russell 2000 is down 0.79%. ====== Update-3...
Update—Later Today…Site Problems yesterday? update 12/21
update 12/21...Looks like all problems have been cleared and content visible. ====== You may have experienced site problems yesterday related to hosting but all content should be available today; update later today.
Rayno Life Science Portfolio Updates-AMRN GNMK TDOC ; XBI is up 30% YTD…Update-12/17
Update-12/17. Amarin (AMRN)- A Sell on the News? AMRN stock tanked another 6.7% today on last weekend's news of the FDA approval of VASCEPA. This is what happens with momentum stocks with a well know story.The stock moved from the $25 level at Friday's close to $21.34 today on ridiculous volume...
Two Early Stage Biopharma Deals Focus on Oncology Assets…ARQL THOR…Update-1
Update-1 ...12/12/19...China Deal Announcement Boosts Dow S&P and NASDAQ. IBB up 0.68%, XBI up 0.58%, XLV up 0.93%. Large cap leaders: ABBV ALXN BMY, Chips, energy, financials strong; real estate weak. 10 year yield moves up to 1.894% =========== Early Stage Pipeline Deals Diversify...
Biotech Scoreboard-November: Gene Therapy Stocks Gain Momentum…Update-2– BOLD
Update-2 ...12/3...Biotech among the leading sectors on a sell-off day With NASDAQ off 0.55% and the S&P down 0.68%, biotech stocks were oblivious to the trade worries and had a huge rally driven by gene therapy stocks. The XBI was up 1.47% and most mid caps were green. RNAi platform...